The Agency for Healthcare Research and Quality (AHRQ) has requested public scientific information submissions on vitamin D and calcium that it intends to use in its “Vitamin D and Calcium: A Systematic Review of Health Outcomes” project, a regulatory review conducted under section 1013 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 and section 902(a) of the Public Health Service Act. Specifically, the agency seeks information from ongoing and completed studies that report on vitamin D and calcium, including those describing adverse events. AHRQ will accept submissions until August 2, 2013. See Federal Register, July 3, 2013.